aescuvest international GmbH
Ansprechpartner: Frank Schwarz
Tel.: +49 69 25474 1644


Business news for the stock market

aescuvest international GmbH: BOCAhealthcare and Surge-on Medical receive awards for "Most innovative products"

Renowned award goes to two companies with ongoing financing rounds on aescuvest

Frankfurt/Munich (pta/18.09.2019/12:28 UTC+2) Every year in September, the pharmaceutical and medical industry turn all eyes on Munich. Then the awards "The Golden Pill" and "The Most Innovative Product", also known as Pharma Oscars, are presented in the Deutsches Museum. This year, BOCAhealthcare and Surge-on Medical took first and second place in the "Startups" category.

"We congratulate the teams from BOCAhealthcare and Surge-on Medical on this award and are proud that the innovativeness of the two companies presented at aescuvest has been so prominently acknowledged by independent experts in the form of the Pharma Awards", says aescuvest CEO Dr. Patrick Pfeffer. "The experts' assessment is the same as that of our Investment Committee whose positive opinion is a prerequisite for the launch of a campaign." Via the platforms that are exclusively geared to healthcare companies, also private investors can participate in start-ups from the most innovative and economically significant sector in Europe. To increase security for investors, an advisory board at aescuvest reviews the plausibility and innovativeness of each submitted project.

BOCAhealthcare has developed a portable body composition analyzer device connected to a smartphone application. The system can to easily monitor patients' hydration and nutritional status, as well as heart rate volume and systemic vascular resistance. The Berlin-based company with Italian roots is currently running an equity crowdfunding campaign on

Surge-on Medical is developing and selling fully steerable, quick detachable and easy to clean instruments for minimally invasive arthroscopy and laparoscopy. In addition, the Dutch MedTech start-up aims to develop the future of remote-controlled robotics in precision surgery. The modular and reusable instruments are ready to be connected to robots. Via the company now intends to raise at least Eur 3 million by ways of a prospectus-based security offering.

Since the year 2000 the most innovative and sustainable companies in the "Rx" category have been honoured annually, and since 2018 in the categories "OTC", "Orphan Drugs" and "Startups", in 2019 the category "Specialty Care" has been added. The decision is based on the Pharma Trend survey, which is conducted among doctors, pharmacists and patients. In the "Startups" category, the winners are determined by a jury of 10 experts with many years of experience in biotechnology, medical technology, M&A and management, as well as in medicine and marketing of pharmaceuticals.

The event of Eurecon Media Group is under the patronage of the Bavarian State Ministry of Health and Care.

aescuvest is the first pan-European crowdfunding platform exclusively dedicated to the health sector, a dynamic market that is large in size, shows sustained growth rates and is driven by innovation. The platform offers retail investors, business angels and venture capitalists opportunities to make entrepreneurial investments in a promising market with above average returns. For start-up companies it serves as an independent launch pad to finance and market smart ideas, with the potential to directly target up to 550,000 healthcare professionals as well as general public all over Europe. Based in the financial hub of Frankfurt, was started as a platform for crowdfunding campaigns for Germany in 2015, bringing innovations in medtech, biotech, health service, digital health and health rentals to life. In 2018, the start of marked the premier of the first platform to offer cross-border equity crowdfunding for healthcare companies and investors all over Europe:


Emitter: aescuvest international GmbH
Hanauer Landstraße 328-330
60314 Frankfurt am Main
Contact Person: Frank Schwarz
Phone: +49 69 25474 1644
ISIN(s): DE000A2PN2F4 (Genussrecht)
Stock Exchange(s): -